Sanofi Aktie

102,96 EUR -0,34 EUR -0,33 %

20.02.2025

FSE

102,78 EUR -0,24 EUR -0,23 %

20.02.2025

GVIE

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.129,22 Mrd. EUR

KGV21,10Div. Rendite4,18%

WKN920657

ISINFR0000120578

SymbolSNYNF

Sanofi Aktien News

Sortieren:Datum Meistgelesen

19.02.25GlobeNewswirePress Release: Sanofi and CD&R sign Opella share purchase agreement

18.02.25GlobeNewswirePress Release: Dupixent sBLA accepted for FDA priority review for the targeted treatment of bullous pemphigoid

13.02.25GlobeNewswirePress Release: Filing of the 2024 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report

WerbungSanofi-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

13.02.25GlobeNewswirePress Release: Update on extraintestinal pathogenic E. coli vaccine phase 3 clinical study

07.02.25GlobeNewswirePress Release: Execution of a share buyback agreement for up to €2 billion

03.02.25BenzingaSanofi Buys Back ~$3 Billion In Shares From L'Oréal: Details

03.02.25GlobeNewswirePress Release: Sanofi announces buy back of shares from L’Oréal

31.01.25GlobeNewswirePress Release: Sarclisa is the first anti-CD38 treatment approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant

30.01.25MotleyFoolSanofi (SNY) Q4 2024 Earnings Call Transcript

30.01.25ZacksSanofi Misses on Q4 Earnings & Sales, Expects Higher Profits in 2025

30.01.25Business TimesSanofi plans 5 billion-euro buyback, sees higher profit growth

30.01.25GlobeNewswirePress Release: Q4 sales growth of 10.3%, 2024 business EPS guidance exceeded, and strong business EPS rebound expected in 2025

29.01.25GlobeNewswireSanofi: Information concerning the total number of voting rights and shares - December 2024

22.01.25BenzingaSanofi Genzyme Facility Draws FDA Criticism Over Alleged Quality Lapses

22.01.25GlobeNewswirePress Release: Sarclisa approved in the EU as the first anti-CD38 therapy in combination with standard-of-care VRd to treat transplant-ineligible newly diagnosed multiple myeloma

21.01.25GlobeNewswirePress Release: Opella reaches study milestone for Cialis

15.01.25GlobeNewswireSanofi: Information concerning the total number of voting rights and shares – November 2024

13.01.25GlobeNewswirePress Release: Sarclisa obtains first approval in China for the treatment of adult patients with relapsed or refractory multiple myeloma

10.01.25BenzingaPrice Over Earnings Overview: Sanofi

09.01.25GlobeNewswirePress Release: New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma

07.01.25ZacksSanofi Down 10% in 3 Months: How Should You Play the Stock?

25.12.24BenzingaA Look Into Sanofi Inc's Price Over Earnings

24.12.24ZacksThe Zacks Analyst Blog Highlights ServiceNow, AMD, Sanofi, Team and United-Guardian

23.12.24ZacksTop Research Reports for ServiceNow, AMD & Sanofi

23.12.24GlobeNewswirePress Release: Sanofi initiates phase 3 program for PCV21 and expands collaboration with SK bioscience for next-generation pneumococcal conjugate vaccines

19.12.24GlobeNewswirePresse release: Jean-Paul Kress to join Sanofi's Board of Directors

18.12.24ZacksStrength Seen in Sanofi (SNY): Can Its 6.7% Jump Turn into More Strength?

17.12.24BenzingaWhy Are Teva And Sanofi Stocks Trading Higher On Tuesday?

17.12.24GlobeNewswirePress Release: Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn’s disease

17.12.24GlobeNewswirePress Release: Availability of the Q4 2024 Aide-mémoire

13.12.24GlobeNewswirePress Release: Tolebrutinib designated Breakthrough Therapy by the FDA for non-relapsing secondary progressive multiple sclerosis

11.12.24GlobeNewswirePress Release: Two combination vaccine candidates for prevention of influenza and COVID-19 granted Fast Track designation in the US

09.12.24GlobeNewswirePress Release: ASH: Sarclisa combinations demonstrated significant benefits in newly diagnosed multiple myeloma patients

07.12.24GlobeNewswirePress Release: ASH: rilzabrutinib demonstrated significant patient benefit in the first positive phase 3 study of a BTK inhibitor in ITP

06.12.24GlobeNewswirePress Release: Availability of the revised financial statements for Sanofi excluding Opella

02.12.24Business TimesSanofi announces biggest China investment deal amid China-EU trade tensions

27.11.24Business TimesSanofi boosts preparedness with S$800 million Singapore plant

20.11.24GlobeNewswireSanofi: Information concerning the total number of voting rights and shares - October 2024

15.11.24GlobeNewswirePress Release: Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria

14.11.24GlobeNewswirePress Release: Sarclisa recommended for EU approval by the CHMP to treat transplant-ineligible newly diagnosed multiple myeloma

Sanofi News

Sanofi News: auf dieser Seite finden Sie alle Sanofi News und Nachrichten zur Sanofi Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Sanofi News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Sanofi News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.